The great obesity drug scare of 2023 is now behind ResMed as evidence in the December quarter suggests GLP-1s are actually a ...

January ended on a slow note as Canadian import tariffs and DeepSeek disruption concerns weighed on buyer sentiment ...

All paying members at FNArena are being reminded they can set an email alert specifically for The Overnight Report. Go to ...

"Like many pet owners, it’s clear that millennials consider their pets as part of their family. But the fact that almost 15% acquired their pets solely to be their support animal shows how emotionally ...

The Channel Company at the helm of CRN Australia, continues the expansion of the flagship CRN brand into new regions which included the 2023 launch of CRN Germany and 2024 launch of CRN Asia. CRN’s ...

Our most recent update was on 12 November when we noted that the upside break was a buying opportunity. After rallying towards the high $90’s in December, JBH then underwent another sideways ...

The weekend tariff announcement may not be taken well by US equity futures, or risk FX on open, but it certainly validates ...

Earnings for Kogan.com missed expectations in the second quarter and most analysts do not share Canaccord Genuity's optimism ...

The head & shoulders reversal pattern remains front and centre. It’s also a pattern that could potentially prove to be a ...

Whitehaven Coal's December quarter production was solid and sales surprised to the upside, but on weaker pricing ...

Following Coronado Global Resources' fourth quarter update, analysts focus on operational improvements and upside from the ...

Post the completion of the Fission acquisition, UBS points to estimated free cash flow around US$10m in 1H25 and cash on hand ...